Sumitomo Mitsui Trust Group’s Roivant Sciences ROIV Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$35.6M	Buy	+974,130	New	+$35.3M	0.02%	523

Other funds holding ROIV

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return

Daiwa Securities Group Tokyo, Japan $53.6B AUM 32.29% 1-Year Est. Return

Penn Davis McFarland Dallas, Texas $1.17B AUM 26.22% 1-Year Est. Return

Parkside Financial Bank & Trust Saint Louis, Missouri $1.51B AUM 17.86% 1-Year Est. Return

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

Cache Advisors San Francisco, California $1.63B AUM 33.42% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return

Amalgamated Bank New York $14.3B AUM 35.81% 1-Year Est. Return

Sumitomo Mitsui Trust Group's ROIV Position: Q3 2026 in Review

Sumitomo Mitsui Trust Group opened a new position in Roivant Sciences (ROIV) in Q3 2026: 974,130 shares worth $35.6M. The stake represents 0.02% of the portfolio and ranks #523 among its holdings.

135 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.

Sumitomo Mitsui Trust Group held 974,130 shares of Roivant Sciences worth $35.6M as of Q3 2026.
Roivant Sciences was a new Sumitomo Mitsui Trust Group position in Q3 2026.
Roivant Sciences made up 0.02% of Sumitomo Mitsui Trust Group's portfolio in Q3 2026, its #523 holding.
135 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q3 2026, filed 29 Oct 2026.